“worse without the Lock Downs?”
Sweden: Aug 21. 2-21 post-analysis.
Sweden decided not to implement a full-scale lockdown during the pandemic.
It now has up to 10 times as many COVID-19 deaths per capita as its Nordic neighbors.
Sweden also didn't fare much better economically, suggesting its gamble didn't pay off.
That’s just the first one I found. Perhaps others say the opposite.
" will the benefits of the Lock Downs have exceeded the costs?"
It’s not going to be easy to convert to money so you can make a comparison. What is the value of a hospital ICU that is not at 110% of capacity? What is the value of an open ER? At the worst point in Los Angeles, there were many cases of people who were driven around for half a day trying to find a place that had room to take them.
I understand the problem of an exponential increase in cases and a limited capacity of hospitals to care for them. Unpopular as lockdowns were, the prospect of bodies on the curb (like in Equador) put the medical authorities in a bind. All I can say is that I am glad I didn’t have to make the decisions.
Mentioned this in a previous post.
https://www.nature.com/articles/d41586-021-03546-8
And this is a report from the NEJM.
https://www.nejm.org/doi/full/10.1056/NEJMe2117446?query=TOC&cid=NEJM%20eToc,%20December%202,%202021%20DM510980_NEJM_Non_Subscriber&bid=724169573
It analyzes the difference between the two mRNA vaccines in a huge VA database.
Last paragraph.
“So let’s review what this study means and consider what it does not mean. We have two vaccines that vary slightly in effectiveness, although they are both highly effective. For any given person, the difference in vaccine efficacy between BNT162b2 and mRNA-1273 is unmeasurable. In the United States, the availability of two mRNA vaccines has allowed us to ramp up vaccination efforts far more quickly than if we had had only one. The need in much of the rest of the world is enormous, and meeting it will require both mRNA vaccines, along with others that are currently being developed and deployed. Even if they are less able to protect against infection, many of the other available vaccines do a very good job of protecting against severe disease. Moreover, the study by Dickerman et al. gives us no idea how the vaccines will compare after an additional booster dose. So the lesson we take away is not about differences — it’s about similarities. We are lucky to have such good options. Vaccination with any vaccine is far better than remaining unprotected. The message is that the best vaccine is the one that’s available.”